CSIMarket
 


Orasure Technologies Inc  (OSUR)
Other Ticker:  
 
 

OSUR's Operating Income Growth by Quarter and Year

Orasure Technologies Inc's Operating Income results by quarter and year




OSUR Operating Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 3.90 13.44 -9.37 4.39
III Quarter September 10.89 0.88 -13.01 -9.40
II Quarter June -6.43 -21.29 1.80 -8.05
I Quarter March 24.32 -15.98 10.42 4.09
FY   32.68 -22.95 -10.16 -8.97



OSUR Operating Income fourth quarter 2023 Y/Y Growth Comment
Orasure Technologies Inc reported drop in Operating Income in the fourth quarter 2023 by -71% to $ 3.90 millions, from the same quarter in 2022.
The fall in the fourth quarter 2023 Orasure Technologies Inc's Operating Income compares unfavorably to the Company's average Operating Income doubling of 106.85%.

Looking into fourth quarter 2023 results within Medical Equipment & Supplies industry 4 other companies have achieved higher Operating Income growth. While Orasure Technologies Inc' s Operating Income meltdown of -71% ranks overall at the positon no. 149 in the fourth quarter 2023.

Explain Operating Income growth


OSUR Operating Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December -71 % - - -66.36 %
III Quarter September 1137.5 % - - -
II Quarter June - - - -
I Quarter March - - 154.77 % -67.31 %
FY   - - - -

Financial Statements
Orasure Technologies Inc's fourth quarter 2023 Operating Income $ 3.90 millions OSUR's Income Statement
Orasure Technologies Inc's fourth quarter 2022 Operating Income $ 13.44 millions Quarterly OSUR's Income Statement
New: More OSUR's historic Operating Income Growth >>


OSUR Operating Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December -64.21 % 1427.27 % - -
III Quarter September - - - -
II Quarter June - - -82.73 % -
I Quarter March 80.95 % - 137.36 % -68.66 %
FY (Year on Year)   - - - -




Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #5
Healthcare Sector #15
Overall #149

Operating Income Y/Y Growth Statistics
High Average Low
2004.38 % 106.85 % -1374.03 %
(March 31, 2016)   (Sep 30 2022)
Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #5
Healthcare Sector #15
Overall #149
Operating Income Y/Y Growth Statistics
High Average Low
2004.38 % 106.85 % -1374.03 %
(March 31, 2016)   (Sep 30 2022)

Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Orasure Technologies Inc's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
1435.43 % 98.43 % -82.75 %
(Dec 31 2022)  


OSUR's IV. Quarter Q/Q Operating Income Comment
In the IV. Quarter 2023 Orasure Technologies Inc realized fall in Operating Income from the third quarter by -64.21% to $ 3.90 millions, from $ 10.89 millions released a quarter before.

Albeit seasonal influence commonly fuel IV. Quarter 2023 Operating Income, that clearly was not substantial to recover Medical Equipment & Supplies's company achievement, Mason Lewis, Medical Equipment & Supplies industry observer wrote and mentioned that average sequential Operating Income growth is at 98.43% for the Medical Equipment & Supplies's company.

Within Medical Equipment & Supplies industry 38 other companies have achieved higher Operating Income quarter on quarter growth. While Orasure Technologies Inc's Operating Income growth quarter on quarter, overall rank is 1321.


Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #39
Healthcare Sector #98
Overall #1321
Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #39
Healthcare Sector #98
Overall #1321
Operating Income Q/Q Growth Statistics
High Average Low
1435.43 % 98.43 % -82.75 %
(Dec 31 2022)  


OSUR's IV. Quarter Q/Q Operating Income Comment
In the IV. Quarter 2023 Orasure Technologies Inc disclosed fall in Operating Income sequentially by -64.21% to $ 3.90 millions, from $ 10.89 millions declared a quarter before.

Even cyclical influence which usually elevate IV. Quarter 2023 results, it clearly has not been substantial to recover Medical Equipment & Supplies's company IV. Quarter outcome, Mason Lewis, Medical Equipment & Supplies industry observer said and wrote that average quarter on quarter Operating Income growth is at 98.43% for Orasure Technologies Inc.

Within Medical Equipment & Supplies industry 38 other companies have achieved higher Operating Income quarter on quarter growth. While Orasure Technologies Inc's Operating Income growth quarter on quarter, overall rank is 1321.


Orasure Technologies Inc's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Operating Income 12 Months Ending $ 32.68 $ 42.22 $ 32.20 $ 17.34 $ -22.96
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) -22.59 % 31.11 % 85.69 % - -
Seq. Operating Income Growth (TTM) Overall Ranking # 149 # 185 # 277 # 0 # 0




Cumulative Operating Income growth Comment
In the Dec 31 2023 period, Orasure Technologies Inc had cumulative twelve months Operating Income of $ 33 millions compare to Operating Loss of $ -23 millions a year ago.

Orasure Technologies Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
2004.38 %
106.85 %
-1374.03 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 15
S&P 500 # 149
Cumulative Operating Income growth Comment
In the Dec 31 2023 period, Orasure Technologies Inc had cumulative twelve months Operating Income of $ 33 millions compare to Operating Loss of $ -23 millions a year ago.

Orasure Technologies Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
2004.38 %
106.85 %
-1374.03 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 15
S&P 500 # 149




Other Operating Income Growth
Medical Equipment & Supplies Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
OSUR's Operating Income Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for OSUR's Competitors
Operating Income Growth for Orasure Technologies Inc's Suppliers
Operating Income Growth for OSUR's Customers

You may also want to know
OSUR's Annual Growth Rates OSUR's Profitability Ratios OSUR's Asset Turnover Ratio OSUR's Dividend Growth
OSUR's Roe OSUR's Valuation Ratios OSUR's Financial Strength Ratios OSUR's Dividend Payout Ratio
OSUR's Roa OSUR's Inventory Turnover Ratio OSUR's Growth Rates OSUR's Dividend Comparisons



Companies with similar Operating Income fall for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Dec 31 2023
Cadre Holdings Inc -0.36%$ -0.362 millions
Prestige Consumer Healthcare Inc -0.40%$ -0.404 millions
Phibro Animal Health Corporation-0.90%$ -0.903 millions
Inmode Ltd -1.11%$ -1.109 millions
Resmed Inc -1.82%$ -1.820 millions
Essa Pharma inc -3.45%$ -3.446 millions
Bausch and Lomb Corp-3.92%$ -3.922 millions
National Research Corporation-4.35%$ -4.346 millions
Vertex Pharmaceuticals Inc-4.35%$ -4.354 millions
Fresenius Medical Care Ag-9.41%$ -9.414 millions
Edwards Lifesciences Corporation-10.65%$ -10.652 millions
Regeneron Pharmaceuticals Inc -15.16%$ -15.164 millions
Harmony Biosciences Holdings inc -15.58%$ -15.578 millions
Charles River Laboratories International inc -18.86%$ -18.856 millions
Biogen Inc -19.42%$ -19.417 millions
Mettler toledo International Inc -19.91%$ -19.915 millions
Bristol myers Squibb Company-20.65%$ -20.646 millions
Qiagen N v -22.87%$ -22.866 millions
Baxter International Inc -22.95%$ -22.946 millions
Artivion Inc -23.20%$ -23.196 millions
Bio rad Laboratories Inc -24.46%$ -24.460 millions
Hologic Inc-24.47%$ -24.466 millions
Becton Dickinson And Company-24.96%$ -24.957 millions
Mesoblast Ltd-25.69%$ -25.686 millions
Sanofi-26.10%$ -26.098 millions
Amedisys Inc -26.45%$ -26.448 millions
Avantor Inc -27.20%$ -27.204 millions
Gilead Sciences Inc -28.89%$ -28.893 millions
Semler Scientific Inc -30.28%$ -30.282 millions
Pro dex Inc -31.66%$ -31.662 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com